LONDON, ON, Jan. 09, 2007 – KGK Synergize Inc. (“KGK”), a nutraceutical product development and contract research organization, today announced the completion of its amalgamation and expansion of its Corporate head office and clinic. The new clinic location has been custom designed to include multiple examination rooms, a secure product storage/dispensing room and a comfortable atmosphere for subjects who join KGK’s ongoing clinical trials.
“KGK has been growing at a rapid rate and it was time to relocate to accommodate this growth” stated Robert Guthrie, VP, Contract Research Services Division. The clinic now has multiple offices and several workstations to accommodate the addition of two new medical doctors, Dr. Dale Wilson and Dr. Tim MacDonald who are sub-investigators joining Dr. David Crowley who has been with KGK over two years as its Principle Investigator. Also joining the clinic team is Ms. Jody Gleeson, B.Sc, CCRP, a second clinical trials coordinator. “As KGK’s corporate office was outgrown, it just made sense to remain in our current office building, but to move to another suite with more space”, stated Mr. Guthrie. Also joining KGK’s corporate office team is Ms. Lauren Anderson, Customer Sales Representative, and Ms. Linda Kotani, Clinical Support Staff.
About KGK Synergize Inc:
KGK Synergize provides contract research services to the health nutrition, biotechnology and pharmaceutical industries which include analytical chemistry, in vitro assays, in vivo models, toxicology and human clinical trials.
In addition to its contract research capabilities, KGK has a Product Development Division which brings new and innovative natural health products to the point where they are ready to be manufactured and marketed. These products include SytrinolTM for cardiovascular health, DiabetinolTM for the treatment and/or prevention of Type II Diabetes, and DermytolTM, a new product for the protection of sun damage to the skin.
For further information, contact:
Kristen Reynolds, Associate Director, Marketing & Sales
519-438-9374 Ext. 222